ARTICLE | Clinical News
NT-0102 regulatory update
February 9, 2015 8:00 AM UTC
Neos submitted an NDA to FDA for NT-0102 to treat ADHD. The extended-release oral disintegrating tablet formulation of generic methylphenidate uses Neos’ Rapidly Disintegrating Ionic Masking (RDIM) te...